18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: OncoTarget 5 (2014),17, S. 7381-7391
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2015
- Creator
-
Lückerath, Katharina
Lapa, Constantin Frederik Victor
Malzahn, Uwe
Samnick, Samuel
Einsele, Herrmann
Buck, Andreas K.
Herrmann, Ken
Knop, Stefan
- URN
-
urn:nbn:de:bvb:20-opus-113107
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lückerath, Katharina
- Lapa, Constantin Frederik Victor
- Malzahn, Uwe
- Samnick, Samuel
- Einsele, Herrmann
- Buck, Andreas K.
- Herrmann, Ken
- Knop, Stefan
- Universität Würzburg
Time of origin
- 2015
Other Objects (12)
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
OP247 Role of PSMA-PET/CT in biochemical relapse during follow-up of prostate cancer patients [Abstract]
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Lenvatinib : Multikinaseinhibitoren - die erste effektive Therapie für das Radiobiod-refraktäre differenzierte Schilddrüsenkarzinom
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Primary central nervous system lymphoma and meningioma in DOTATATE PET/CT
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
OP247 Role of PSMA-PET/CT in biochemical relapse during follow-up of prostate cancer patients [Abstract]
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Lenvatinib : Multikinaseinhibitoren - die erste effektive Therapie für das Radiobiod-refraktäre differenzierte Schilddrüsenkarzinom
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Primary central nervous system lymphoma and meningioma in DOTATATE PET/CT
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
OP247 Role of PSMA-PET/CT in biochemical relapse during follow-up of prostate cancer patients [Abstract]
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Lenvatinib : Multikinaseinhibitoren - die erste effektive Therapie für das Radiobiod-refraktäre differenzierte Schilddrüsenkarzinom
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy